ER+ and PR+ Breast Cancer: Key Statistics and Molecular Insights
ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...
Triple-Negative Breast Cancer (TNBC): Understanding Diagnosis and Treatment
TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.